How is DLCO (Diffusing Capacity of the Lung for Carbon Monoxide) measured in a patient with a history of allergic reactions or autoimmune diseases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How DLCO is Measured

DLCO is measured using a single-breath technique where the patient inhales a test gas mixture containing a small amount of carbon monoxide, holds their breath for 10 seconds, and then exhales—a simple maneuver requiring minimal patient effort. 1, 2

The Measurement Technique

The single-breath method is used almost exclusively in the United States and has been the standard for over 50 years. 3 The test procedure involves:

  • Patient breathes quietly at rest, then inhales the test gas mixture to total lung capacity 1
  • Breath-hold period of exactly 10 seconds to allow CO diffusion across the alveolar-capillary membrane 1, 2
  • Patient exhales completely, and the exhaled gas is analyzed 1
  • The test measures CO uptake from alveolar space into pulmonary capillary blood, following the same pathway as oxygen 4

What the Test Actually Measures

DLCO examines two fundamental components of gas transfer:

  • Alveolar volume (VA), measured simultaneously via single-breath helium dilution during the DLCO maneuver 1, 2
  • Transfer coefficient (KCO or DLCO/VA), which represents diffusing capacity per unit of alveolar volume 5, 2

The test captures the underlying pathophysiology guiding oxygen transfer from alveoli into blood. 2

Special Considerations for Patients with Allergies or Autoimmune Disease

The measurement technique itself does not change for patients with allergic reactions or autoimmune diseases—the same single-breath maneuver is used. However, interpretation requires specific adjustments:

  • Hemoglobin correction is mandatory in autoimmune patients who may have anemia of chronic disease, as anemia reduces hemoglobin available for CO binding and falsely lowers DLCO 5, 6
  • Carboxyhemoglobin adjustment is important for accurate results, particularly in patients being monitored for drug toxicity (common in autoimmune disease treatment) 5
  • The test is safe and involves only trace amounts of CO—no contraindications exist for allergic or autoimmune patients 1

Technical Quality Control

Strict adherence to lung function standards and guidelines reduces test variability. 5 The measurement requires:

  • Meticulous quality control to ensure reliable results, especially when tracking disease progression over time 5
  • Proper breath-hold time of 10 seconds, as this directly affects the measured value 1
  • Adequate patient cooperation for the inhalation to total lung capacity, though the maneuver requires very little effort compared to spirometry 1

Billing and Documentation

Only CPT code 94720 should be used for DLCO measurement. 3 Code 94725 (membrane diffusing capacity) has no established clinical indications and should not be billed. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.